Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Abdulhamid Hosbas/Anadolu Agency via Getty Images

Pfizer and BioNTech announced Wednesday that their coronavirus vaccine was found to be 100% effective at protecting against COVID-19 in a trial of more than 2,200 children between the ages of 12 and 15.

The big picture: Pfizer CEO Albert Bourla said the companies plan to submit clinical trial data to the FDA for emergency use authorization in the coming weeks, with the hope of vaccinations for adolescents beginning before the start of the next school year.

  • The trial's data will also be submitted to the European Medicines Agency (EMA) for emergency use authorization.

What they're saying: "Across the globe, we are longing for a normal life. This is especially true for our children," said Ugur Sahin, CEO and co-founder of BioNTech.

  • "The initial results we have seen in the adolescent studies suggest that children are particularly well protected by vaccination, which is very encouraging given the trends we have seen in recent weeks regarding the spread of the B.1.1.7 UK variant," he added.

Details: The clinical trial was conducted in the U.S. with 2,260 adolescents ages 12 to 15.

  • The vaccines illustrated "100% efficacy and robust antibody responses," and achieved better results than a previous study conducted on 16-25 year olds.
  • 18 cases of COVID-19 were observed in the group of participants who received a placebo, while none were observed in those who were vaccinated.
  • Pfizer and BioNTech also announced that the first doses were administered last week in a trial of children ages six months to 11 years

Go deeper

Updated Jul 26, 2021 - Politics & Policy

Coronavirus dashboard

Illustration: Brendan Lynch/Axios

  1. Vaccines: Benefits of J&J COVID-19 vaccine outweigh risks, per CDC data — Why vaccinated America can't turn its back on unvaccinated America.
  2. Health: A reality check on the GOP's push for coronavirus antibody testing — NYC to require COVID vaccination or weekly testing for city workers — Over 50 medical groups call for mandatory vaccinations for health care workers — Savannah reimposes indoor mask mandate.
  3. Politics: Biden: Americans with long-COVID symptoms may qualify for disability resources — Prominent Republicans find new enthusiasm for COVID-19 vaccines — GOP Rep. Clay Higgins says he has COVID for second time.
  4. Sports: Golfer Bryson DeChambeau will miss Olympics after testing positive for COVID— NFL raises vaccine pressure
  5. World: Israel to require vaccine certificates to attend social events.
  6. Variant tracker: Where different strains are spreading.
Updated Mar 30, 2021 - World

WHO chief: Virus investigators had difficulties "accessing raw data" from China

Photo: Peace One Day via Getty Images

World Health Organization director-general Tedros Adhanom Ghebreyesus welcomed the joint WHO-China report on the origins of the coronavirus on Tuesday, but he noted that scientists had difficulty "accessing raw data" from China and called for further investigation of the lab leak theory.

Why it matters: The comments come in the wake of an inconclusive report that has prompted concerns about transparency and the influence of the Chinese government over the investigation.

Mar 30, 2021 - World

U.S. women won’t reach pay equity with men for at least 60 years

Data: WEF; Chart: Axios Visuals

Despite some progress, it will take women in North America approximately 61.5 years to have economic parity with men according to the World Economic Forum's Global Gender Gap Report for 2021.

Why it matters: Women in the U.S. have made strides in political representation, but they still lag behind men in job market participation and income, according to the report.